- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dietary Restrictions Could Prevent Colon Cancer
The study, published in JAMA Internal Medicine, found that while the complete absence of meat in the diet had the most impact on reducing the risk of colorectal cancer, those who added seafood to the vegetarian diet-pescovegetarians-faired better than the nonvegetarians.
A vegetarian diet, especially one that includes fish, significantly reduces the risk of colorectal cancer, a large new study reports.
Researchers recruited 77,659 men and women from Seventh-day Adventist churches nationwide. All filled out well-validated questionnaires that included more than 200 food items.
Meat intake in the population was very low—an average of about 2 ounces a day. During an average of 7 years of follow-up, the scientists found 490 cases of colorectal cancer. Over all, after adjusting for many health and behavioral variables, vegetarians had a 21% reduced risk of cancer compared with nonvegetarians. The results are in JAMA Internal Medicine.
Read the report in The New York Times:
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
